Class information for:
Level 1: SOMATOSTATIN RECEPTOR SCINTIGRAPHY//PEPTIDE RECEPTOR RADIONUCLIDE THERAPY//OCTREOTATE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4749 1658 34.7 86%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
762 11723 NEUROENDOCRINE TUMORS//CARCINOID//GASTRINOMA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SOMATOSTATIN RECEPTOR SCINTIGRAPHY Author keyword 71 50% 6% 103
2 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY Author keyword 69 66% 4% 64
3 OCTREOTATE Author keyword 38 78% 2% 25
4 MINIGASTRIN Author keyword 38 93% 1% 14
5 RECEPTOR SCINTIGRAPHY Author keyword 35 81% 1% 21
6 PRRT Author keyword 34 54% 3% 43
7 IN 111 PENTETREOTIDE Author keyword 33 53% 3% 44
8 Y 90 DOTATOC Author keyword 31 74% 1% 23
9 RADIOL CHEM Address 31 47% 3% 48
10 LU 177 OCTREOTATE Author keyword 30 84% 1% 16

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 SOMATOSTATIN RECEPTOR SCINTIGRAPHY 71 50% 6% 103 Search SOMATOSTATIN+RECEPTOR+SCINTIGRAPHY Search SOMATOSTATIN+RECEPTOR+SCINTIGRAPHY
2 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY 69 66% 4% 64 Search PEPTIDE+RECEPTOR+RADIONUCLIDE+THERAPY Search PEPTIDE+RECEPTOR+RADIONUCLIDE+THERAPY
3 OCTREOTATE 38 78% 2% 25 Search OCTREOTATE Search OCTREOTATE
4 MINIGASTRIN 38 93% 1% 14 Search MINIGASTRIN Search MINIGASTRIN
5 RECEPTOR SCINTIGRAPHY 35 81% 1% 21 Search RECEPTOR+SCINTIGRAPHY Search RECEPTOR+SCINTIGRAPHY
6 PRRT 34 54% 3% 43 Search PRRT Search PRRT
7 IN 111 PENTETREOTIDE 33 53% 3% 44 Search IN+111+PENTETREOTIDE Search IN+111+PENTETREOTIDE
8 Y 90 DOTATOC 31 74% 1% 23 Search Y+90+DOTATOC Search Y+90+DOTATOC
9 LU 177 OCTREOTATE 30 84% 1% 16 Search LU+177+OCTREOTATE Search LU+177+OCTREOTATE
10 SOMATOSTATIN RECEPTOR IMAGING 29 72% 1% 23 Search SOMATOSTATIN+RECEPTOR+IMAGING Search SOMATOSTATIN+RECEPTOR+IMAGING

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 Y 90 DOTATOC 154 73% 7% 119
2 SOMATOSTATIN RECEPTOR SCINTIGRAPHY 104 31% 17% 276
3 IN 111 PENTETREOTIDE 83 73% 4% 64
4 RADIOLABELED SOMATOSTATIN ANALOG 83 60% 5% 91
5 GA 68 DOTA TYR3 OCTREOTIDE PET 82 81% 3% 50
6 RADIONUCLIDE THERAPY 80 30% 13% 222
7 TYR3 OCTREOTATE 75 91% 2% 31
8 INITIAL CLINICAL EVALUATION 70 82% 2% 41
9 LU 177 DOTA0 TYR3 OCTREOTATE 59 84% 2% 32
10 DOTATOC 57 95% 1% 19

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Lutetium-labelled peptides for therapy of neuroendocrine tumours 2012 35 50 78%
SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH [IN-111-DTPA-D-PHE(1)]- AND [I-123-TYR(3)]-OCTREOTIDE - THE ROTTERDAM EXPERIENCE WITH MORE THAN 1000 PATIENTS 1993 1028 52 46%
Neuroendocrine tumours: the role of imaging for diagnosis and therapy 2014 9 90 61%
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors 2010 122 104 59%
(68)Gallium- and (90)Yttrium-/(177)Lutetium: "theranostic twins" for diagnosis and treatment of NETs 2015 1 46 74%
Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis 2013 17 49 78%
Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer 2012 51 135 41%
Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms 2012 26 82 71%
Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings 2002 182 29 76%
Tumor Imaging and Therapy Using Radiolabeled Somatostatin Analogues 2009 65 45 73%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RADIOL CHEM 31 47% 2.9% 48
2 RADIOL CHEM UNIT 23 100% 0.6% 10
3 CELL BIOL EXPT CANC 17 28% 3.0% 50
4 INTERDISCIPLINARY NEUROENDOCRINE TUMORS GASTR 6 80% 0.2% 4
5 S RADIOPHARMACEUT MOL IMAGING 6 80% 0.2% 4
6 WARD THORAC SURG 6 100% 0.2% 4
7 DIAGNOST IMAGING RADIOISOTOPE THER Y SERV 4 67% 0.2% 4
8 MOL RADIOTHER Y MOL IMAGING 4 67% 0.2% 4
9 UNIT RADIOMETAB MED 3 100% 0.2% 3
10 CHARITE DIAGNOST INTERVENT RADIOL NUKL ME 3 60% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000198756 GE 68 GA 68 GENERATOR//GALLIUM 68//GA 68
2 0.0000186962 SOMATOSTATIN//SOMATOSTATIN RECEPTORS//SOMATOSTATIN RECEPTOR
3 0.0000168545 NEUROENDOCRINE TUMORS//CARCINOID//CARCINOID HEART DISEASE
4 0.0000112243 MELANOMA IMAGING//IMAGERIE MOL THER IE VECTORISEE//MELANOMA TARGETING
5 0.0000101878 I 131 MIBG//MIBG//METAIODOBENZYLGUANIDINE
6 0.0000097329 INSULINOMA//GASTRINOMA//ZOLLINGER ELLISON SYNDROME
7 0.0000095054 BETA CELL IMAGING//BETA CELL MASS//DTBZ
8 0.0000081141 RADIOIMMUNOTHERAPY//PRETARGETING//Y 90 IBRITUMOMAB TIUXETAN
9 0.0000072151 EGF DEXTRAN//ANTIBODY BINDING PARAMETERS//BIOMED RADIAT SCI
10 0.0000066054 BOMBESIN//GASTRIN RELEASING PEPTIDE//GASTRIN RELEASING PEPTIDE RECEPTOR